101 related articles for article (PubMed ID: 7132736)
1. Impaired prolactin responsiveness to dopamine antagonists in acromegaly.
Camanni F; Massara F; Santià M; Molinatti GM; Müller EE
Metabolism; 1982 Nov; 31(11):1090-5. PubMed ID: 7132736
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects.
Camanni F; Genazzani AR; Massara F; La Rosa R; Cocchi D; Müller EE
Neuroendocrinology; 1980; 30(1):2-6. PubMed ID: 7354887
[TBL] [Abstract][Full Text] [Related]
3. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
[TBL] [Abstract][Full Text] [Related]
4. Prolactin response to the dopamine antagonists sulpiride and domperidone. Further evidence for pituitary dopamine deficiency in hyperprolactinemic disorders of different etiology.
Ferrari C; Scarduelli C; Rampini P; Brambilla G; Benco R; Pistolesi E; Paracchi A; Mattei A; Boghen M; Crosignani PG
Gynecol Obstet Invest; 1983; 16(5):299-306. PubMed ID: 6642291
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
[TBL] [Abstract][Full Text] [Related]
6. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
[TBL] [Abstract][Full Text] [Related]
7. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
8. Dynamic testing of prolactin and growth hormone secretion in patients with neuroendocrine disorders.
Müller EE; Cavagnini F; Martinez-Campos A; Maraschini C; Giovannini P; Novelli A; De Leo V
Acta Endocrinol (Copenh); 1984 Oct; 107(2):155-63. PubMed ID: 6437104
[TBL] [Abstract][Full Text] [Related]
9. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
Nyquist P; Laws ER; Elliott E
Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
[TBL] [Abstract][Full Text] [Related]
10. Plasma growth hormone responses to sulpiride in patients with acromegaly.
Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
[TBL] [Abstract][Full Text] [Related]
11. Tubero-infundibular dopaminergic function in cirrhotic patients: evaluation by nomifensine and domperidone.
Monza GC; Lampertico M; Locatelli S; Sali L; Cocchi D
Acta Endocrinol (Copenh); 1983 Jul; 103(3):315-20. PubMed ID: 6880568
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
13. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects.
Losa M; Schopohl J; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1985 Aug; 109(4):467-73. PubMed ID: 3929513
[TBL] [Abstract][Full Text] [Related]
15. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.
Ghigo E; Ciccarelli E; Novelli A; Massobrio M; Müller EE; Camanni F
J Endocrinol Invest; 1985 Feb; 8(1):35-40. PubMed ID: 3989236
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
18. Effects of sustained hyperprolactinemia induced by chronic treatment with domperidone on central dopaminergic systems in the rat.
Benfenati F; Ferretti C; Cimino M; Vantini G; Lipartiti M; Muccioli G; Di Carlo R; Algeri S
Pharmacol Res Commun; 1986 May; 18(5):431-49. PubMed ID: 3737655
[TBL] [Abstract][Full Text] [Related]
19. The effect of calcitonin on growth hormone secretion in acromegaly.
Looij BJ; Roelfsema F; Frölich M
Clin Endocrinol (Oxf); 1989 Nov; 31(5):573-9. PubMed ID: 2627752
[TBL] [Abstract][Full Text] [Related]
20. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
Masturzo P; De Maria A; Murialdo G; Bonura ML; Zauli C; Polleri A
J Clin Endocrinol Metab; 1985 Aug; 61(2):378-81. PubMed ID: 4008612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
